Grantopen🌐 United StatesPAR-25-060

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Oct 22, 2024
Response deadline: Oct 20, 2027, 12:00 AM UTC (465d)
Type: Grant
Category: 93.853
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-060

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
United States · Oct 22, 2024
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
United States · Nov 4, 2024
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
United States · Feb 9, 2026
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
United States · Oct 29, 2024
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
United States · Dec 16, 2024
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
United States · Nov 14, 2024

Similar past solicitations

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
United States · Nov 6, 2024
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01 Clinical Trial Not Allowed)
United States · Oct 25, 2024
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
United States · Oct 1, 2024
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
United States · Nov 1, 2023
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.